Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8245101 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 6 Pages |
Abstract
Conclusions: Despite relatively high V20 values in this study of HL patients, the incidence of RP was only 3%, lower compared with the lung cancer literature. We suggest the following clinically relevant parameters be considered in treatment plan assessment: a V20 greater than 36% and an MLD greater than 14 Gy, over and above which the risk of RTOG Grade 2 or greater RP would be considered clinically significant.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Eng-Siew M.D., Alexander M.D., Tu Huan M.R.T., Richard M.D., Melania M.Sc., David C. M.D., M.P.H., Woodrow M.D., Robert Ph.D., Mary K. M.D.,